血管閉塞症の危険性を伴う鎌状赤血球症は、鎌状赤血球貧血の人に起こる痛みを伴う症状です。 症状には、発熱、痛み、疲労、腹痛と腫れ、頭痛、息切れ、脱水、感染症などがあります。 治療には、NSAID、アセトアミノフェン、輸血、手術が含まれます。
目次
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Sickle Cell Disease With Vaso-Occlusive Crisis - Overview
Sickle Cell Disease With Vaso-Occlusive Crisis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Sickle Cell Disease With Vaso-Occlusive Crisis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Sickle Cell Disease With Vaso-Occlusive Crisis - Companies Involved in Therapeutics Development
Alfasigma SpA
Asklepion Pharmaceuticals LLC
Chugai Pharmaceutical Co Ltd
Cyclerion Therapeutics Inc
Global Blood Therapeutics Inc
GlycoMimetics Inc
Hartis Pharma SA
NicOx SA
Novartis AG
NuvOx Pharma LLC
Prolong Pharmaceuticals LLC
Sickle Cell Disease With Vaso-Occlusive Crisis - Drug Profiles
Sickle Cell Disease With Vaso-Occlusive Crisis - Dormant Projects
Sickle Cell Disease With Vaso-Occlusive Crisis - Discontinued Products
Sickle Cell Disease With Vaso-Occlusive Crisis - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Sickle Cell Disease With Vaso-Occlusive Crisis, 2022
Number of Products under Development by Companies, 2022
Products under Development by Companies, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Sickle Cell Disease With Vaso-Occlusive Crisis - Pipeline by Alfasigma SpA, 2022
Sickle Cell Disease With Vaso-Occlusive Crisis - Pipeline by Asklepion Pharmaceuticals LLC, 2022
Sickle Cell Disease With Vaso-Occlusive Crisis - Pipeline by Chugai Pharmaceutical Co Ltd, 2022
Sickle Cell Disease With Vaso-Occlusive Crisis - Pipeline by Cyclerion Therapeutics Inc, 2022
Sickle Cell Disease With Vaso-Occlusive Crisis - Pipeline by Global Blood Therapeutics Inc, 2022
Sickle Cell Disease With Vaso-Occlusive Crisis - Pipeline by GlycoMimetics Inc, 2022
Sickle Cell Disease With Vaso-Occlusive Crisis - Pipeline by Hartis Pharma SA, 2022
Sickle Cell Disease With Vaso-Occlusive Crisis - Pipeline by NicOx SA, 2022
Sickle Cell Disease With Vaso-Occlusive Crisis - Pipeline by Novartis AG, 2022
Sickle Cell Disease With Vaso-Occlusive Crisis - Pipeline by NuvOx Pharma LLC, 2022
Sickle Cell Disease With Vaso-Occlusive Crisis - Pipeline by Prolong Pharmaceuticals LLC, 2022
Sickle Cell Disease With Vaso-Occlusive Crisis - Dormant Projects, 2022
Sickle Cell Disease With Vaso-Occlusive Crisis - Discontinued Products, 2022
List of Figures
Number of Products under Development for Sickle Cell Disease With Vaso-Occlusive Crisis, 2022
Number of Products under Development by Companies, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022
